Wed.Nov 20, 2024

article thumbnail

STAT+: AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO

STAT

Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company, founded in 1990, started out by making software that used the basic laws of physics to laboriously and exactly predict how molecules will interact with each other in space. Those calculations, rooted in the field of computational physics, needed lots of expensive and time-consuming computing power to run, and many people abandoned those t

article thumbnail

MSD says subcutaneous Keytruda matches IV form

pharmaphorum

MSD's subcutaneous formulation of top-selling cancer drug Keytruda was non-inferior to the current intravenous version in a head-to-head trial

101
101
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: New details on a risky medical device show need for more FDA transparency, researchers say

STAT

Tonya Brand was horrified to find a piece of metal poking out of her inner thigh while relaxing at her house in Georgia in 2011. She had no idea what it could be.  It was only after extensive imaging that her doctors realized what had happened: A medical device that had been implanted in her two years earlier to catch blood clots had broken and was now migrating to different parts of her body.

321
321
article thumbnail

We should call for a new minister to improve men and boys’ health

The Pharmacist

What more can we do to improve men’s health? Pharmacist Michael Achiampong shares his personal viewpoint about improving the health of men and boys. Men and boys’ health – physical, mental and emotional – has rocketed up the healthcare agenda and public awareness like never before.1,2 There is new impetus for some long-running initiatives such as Movember3 […] The post We should call for a new minister to improve men and boys’ health appeared first on The Pharmacist.

86
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: RFK Jr. is exploring a plan to upend Medicare’s physician payments system

STAT

WASHINGTON  — People close to Robert F. Kennedy Jr. are exploring a proposal that could upend how physician payment is determined in America, four sources familiar with the process told STAT.

361
361
article thumbnail

Latest UKHSA figures show rise in both antibiotic use and resistance

The Pharmacist

Antibiotic use rose by 2.4% year-on-year in 2023 and prescribing levels are now in line with those seen in 2019, according to national surveillance data published by the UK Health Security Agency (UKHSA). The increases were seen across the majority of antibiotic groups, with penicillins accounting for the most frequently prescribed antibiotic group in primary […] The post Latest UKHSA figures show rise in both antibiotic use and resistance appeared first on The Pharmacist.

86

More Trending

article thumbnail

NICE blames companies for breakdown in Enhertu talks

pharmaphorum

Discussions aimed at making AstraZeneca and Daiichi Sankyo's Enhertu available to breast cancer patients on the NHS have been abandoned

93
article thumbnail

AI-guided decisions can devastate lower-income Americans. This group wants to change that

STAT

In 2016, the Arkansas Legal Aid Center was flooded with calls. People on a Medicaid program that provided in-home care assistance were having their caregiving hours cut. Reducing the hours for somebody with quadriplegia or cerebral palsy was devastating, said Kevin De Liban, an attorney with the organization at the time. “People are lying in their own waste, people are getting bed sores from not being turned.

295
295
article thumbnail

Pfizer bags EU okay for haemophilia drug Hympavzi

pharmaphorum

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU

94
article thumbnail

A new device for delivering drugs without needles draws inspiration from the elegant squid

STAT

Doctors have been using needles as a way to inject people with drugs since the 1600s. Today they’re often used for biologic drugs, which are too large to deliver via pills because they would be dissolved by stomach acid. Now a group of bioengineers is hoping to give drug delivery an update with a device that draws inspiration from cuttlefish and other sea creatures.

293
293
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Ardena’s expanded nanomedicine facility granted full GMP approval

Pharma Times

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles

90
article thumbnail

Opinion: Paying a visit to ‘Mom & Dad’s Nipple Factory’

STAT

When Randi Johnson was undergoing treatment for breast cancer, her husband, Brian, often felt at a loss to help. But then, when he and Randi met with a surgeon to discuss reconstructing her breast, he was struck by something he could do. The Midwestern father of five, a lifelong tinkerer, decided to make his wife the best possible prosthetic nipple.

268
268
article thumbnail

Tran Pham: Breaking barriers and building biopharma solutions

Outsourcing Pharma

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has built a dynamic career in biopharma.

75
article thumbnail

STAT+: Kura licenses leukemia drug to Japanese drugmaker

STAT

Kura Oncology has signed a global partnership with the Japanese drugmaker Kyowa Kirin to develop and sell Kura’s experimental treatment for acute leukemia, the companies said Wednesday.  Kyowa is paying $320 million to Kura in exchange for global licensing rights to the drug, called ziftomenib, which is in a late-stage clinical trial for a genetically defined type of advanced leukemia.

239
239
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Flagship, Pfizer alliance yields two more startup deals

BioPharma Dive

Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for obesity and lung cancer, respectively, adding to collaborations it previously formed with other Flagship startups.

69
article thumbnail

STAT+: Doubling down on its strategy, Pfizer names its head of oncology as new research chief

STAT

Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties overseeing the company’s scientific and commercial efforts in cancer. Boshoff replaces Mikael Dolsten, who led research and development at the drug giant for 15 years and who announced his plans to retire in July.

290
290
article thumbnail

Lord Darzi: Pharmacy closures ‘a grave concern’ that must be investigated by MPs

The Pharmacist

The ongoing closure of community pharmacies across the country is a ‘grave concern’ that should be further investigated by MPs, Lord Ara Darzi has told an inquiry today. The cancer surgeon and former Labour minister was this morning questioned by the Health and Social Care Committee on the findings of his major investigation into the […] The post Lord Darzi: Pharmacy closures ‘a grave concern’ that must be investigated by MPs appeared first on The Pharmacist.

article thumbnail

Investors tell Silence Therapeutics to shush 

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning. Today, we meet Pfizer’s new chief scientific officer, ponder why the stock for Silence Therapeutics dropped despite promising data, and see that pharma executives aren’t too worried about Robert F.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Sage wilts as Huntington's prospect flunks trial

pharmaphorum

Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease

87
article thumbnail

STAT+: Pharmalittle: We’re reading about Pfizer’s new R&D head, Merck and J&J job cuts in China, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. And what better way to make the time fly than to keep busy.

Hospitals 193
article thumbnail

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

Pharmafile

20 November 2024 – Glasgow, UK –: Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.

64
article thumbnail

Chasing new ‘checkpoints,’ startup Valora emerges from a Nobel winner’s lab

BioPharma Dive

Built around research by Stanford scientist Carolyn Bertozzi and MIT researcher Jessica Stark, Valora Therapeutics is designing drugs to target glyco-immune checkpoints.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Lupin launches Bumetanide injection USP in the United States

Express Pharma

On 19 November 2024, Lupin announced the launch of Bumetanide Injection USP in the United States following approval from the United States Food and Drug Administration (FDA). The product is available in two formulations: 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vials. Bumetanide Injection USP is a generic equivalent of Bumex Injection (0.25 mg/mL) by Validus Pharmaceuticals, LLC.

64
article thumbnail

Sage’s string of research failures continues

BioPharma Dive

Negative results from a Huntington’s trial add to a calamitous year for Sage, which last month decided to overhaul its research, reconfigure its executive team and lay off a third of its staff.

61
article thumbnail

AVPN launches Climate x Health: Lighthouse for Asia fund

Express Pharma

AVPN, the largest network of social investors in Asia, has launched the “Climate x Health: Lighthouse for Asia” Fund with support from the Bayer Foundation. Announced during the Singapore Pavilion session at COP29 in Baku, Azerbaijan, the USD 5-million fund aims to assist non-profit organisations utilising climate innovations to develop scalable solutions to protect vulnerable communities from the health impacts of climate change.

article thumbnail

Helen Harrington’s journey: Patience, passion, and problem-solving

Outsourcing Pharma

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harringtonâs journey is one of resilience and curiosity.

67
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Enhance HCP Engagements with Close-Up CRM’s AI Powered Next Best HCP Actions and Dynamic Segmentation Capabilities

Pharmaceutical Commerce

Pharmaceutical companies are transforming how they connect with healthcare professionals (HCPs) by leveraging AI using more complex data and integration strategies. Close-Up CRM incorporates these advancements by leveraging AI to empower teams with precision-targeted engagements, and delivery of the right message to the right HCP at the right time. The intuitive user-friendly platform provides the field intelligence teams with needed information that's always ready.

article thumbnail

Samsung Biologics and European pharma company enter major manufacturing deal

Outsourcing Pharma

The global CDMO has entered into several high-value manufacturing deals this year.

81
article thumbnail

Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence

Pharmaceutical Commerce

As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.

52
article thumbnail

Episode 976: Can 3% (hypertonic) sodium chloride ever be given via a peripheral IV?

Pharmacy Joe

In this episode, I’ll discuss peripheral IV administration of 3% sodium chloride solution. Episode 976: Are there times when 3% (hypertonic) sodium chloride can be given through a peripheral IV? Subscribe on iTunes , Android , or Stitcher Infusions of 3% sodium chloride are routinely recommended to be given through central, not peripheral IV lines. This recommendation is based on the theory that since the osmolarity of 3% sodium chloride exceeds 900 mOsm/L, it puts the patient at risk of thrombo

article thumbnail

Maximizing ROI in Pharma: The Power of Display Advertising for Targeted Campaigns

Pharma Marketing Network

Table of Contents Sr# Headings 1 Introduction 2 What Is Display Advertising? 3 Why Display Advertising Matters in Pharma 4 Key Benefits of Display Advertising 5 Targeting: Reaching the Right Audience 6 Personalization in Display Ads 7 Case Study: Successful Pharma Display Campaigns 8 Choosing the Right Platforms 9 Metrics to Track for ROI Success 10 Regulatory Challenges and Solutions 11 The Role of Branded Drugs in Display Ads 12 Creative Best Practices for Display Ads 13 Aligning Display Ads w